Daniel E. Owens - 01 Jun 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief HR Officer
Signature
/s/ Lisa Taylor as Attorney-in-fact for Dan Owens
Issuer symbol
TMCI
Transactions as of
01 Jun 2022
Net transactions value
-$9,642
Form type
4
Filing time
03 Jun 2022, 17:12:27 UTC
Previous filing
11 May 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Options Exercise $7,028 +1,000 +9.3% $7.03 11,700 01 Jun 2022 Direct F2
transaction TMCI Common Stock Sale $16,670 -1,000 -8.5% $16.67 10,700 01 Jun 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Options Exercise $0 -1,000 -0.5% $0.000000 198,625 01 Jun 2022 Common Stock 1,000 $7.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 6,700 RSUs.
F3 The stock option will vest in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025.